Skip to content

Overview

How It Works

Diversify among both domestic and foreign securities in various asset classes, including stocks, bonds, commodities, and others primarily in shares of mutual funds and exchange-traded funds ("ETFs").

Monitor the asset allocation framework regularly and adjust to align with evolving investment views amid changing market and economic conditions.

The Fund may be suitable for long-term investors looking to diversify a portfolio with both domestic and foreign securities in various asset classes.
Explore other Northern Funds.
Fund Facts

*Includes contractual expense reimbursements that, if not extended, will end on July 31, 2024.

Performance

Performance quoted represents past performance and does not guarantee future results. Investment return and principal value will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than that shown here. Performance data current to the most recent month-end can also be obtained by calling 800-595-9111

 

Above risk characteristics are based on a 3-year time period.

 

Northern Trust Investments, Inc. (“NTI”) has contractually agreed to reimburse a portion of the operating expenses of the Fund so that after such reimbursement the Total Annual Fund Operating Expenses of the Fund (excluding (i) acquired fund fees and expenses; (ii) the compensation paid to each Independent Trustee of the Trust; (iii) expenses of third party consultants engaged by the Board of Trustees; (iv) membership dues paid to the Investment Company Institute and Mutual Fund Directors Forum; (v) expenses in connection with the negotiation and renewal of the revolving credit facility; and (vi) extraordinary expenses and interest) do not exceed 0.25%. NTI has also contractually agreed to reimburse the management fees payable by the Fund in an amount equal to the net management fee NTI earns on the amount invested by the Fund in money market funds managed by NTI. These contractual limitations may not be terminated before July 31, 2024 without the approval of the Board of Trustees.

 

The "Total Annual Fund Operating Expenses After Expense Reimbursement" may be higher than the contractual limitation as a result of the excepted expenses, including but not limited to acquired fund fees and expenses, that are not reimbursed.

 

In the absence of fee waivers, yield, total return, growth since inception and dividends would have been reduced. Total return is based on net change in NAV assuming reinvestment of distributions. Total Returns table performance is calculated using the current benchmark allocation. The returns for the Morningstar or the iMoneyNet Category Average represents a universe of funds with similar objectives.

Distributions

  

Characteristics

  

Exposure Breakdowns

Information is provided to illustrate typical sectors and securities in which the portfolio may invest. It should not be considered investment advice or a recommendation to buy or sell any security. There is no guarantee that securities remain in the portfolio or that securities sold have not been repurchased. It should not be assumed that any investments were profitable or will prove to be profitable, and past performance does not guarantee future results.

Top 10 Holdings

Portfolio holdings are subject to change without notice. The portfolio holdings and allocations will change and the information provided should not be considered as a recommendation to purchase or sell a particular security. There is no assurance that the securities mentioned remain in the Fund’s portfolio or that securities sold have not been repurchased.

Meet the Team

The PM team average 23 years of industry experience with 18 years at Northern Trust.

The investment team includes Northern Trust’s Capital Market Group with leadership from Global Equities, Global Fixed Income, and Quantitative Strategies teams.

Anwiti Bahuguna, Ph.D.

Portfolio ManagerRead Bio

Daniel Ballantine

Portfolio ManagerRead Bio

Timothy Johnson

Portfolio ManagerRead Bio

Literature

Fund Documents

Contact Us

Interested in learning more about our products and solutions?